全文获取类型
收费全文 | 10632篇 |
免费 | 745篇 |
国内免费 | 28篇 |
专业分类
耳鼻咽喉 | 75篇 |
儿科学 | 428篇 |
妇产科学 | 281篇 |
基础医学 | 1569篇 |
口腔科学 | 146篇 |
临床医学 | 1441篇 |
内科学 | 2039篇 |
皮肤病学 | 167篇 |
神经病学 | 1160篇 |
特种医学 | 284篇 |
外科学 | 866篇 |
综合类 | 73篇 |
一般理论 | 125篇 |
预防医学 | 1043篇 |
眼科学 | 204篇 |
药学 | 627篇 |
中国医学 | 9篇 |
肿瘤学 | 868篇 |
出版年
2023年 | 90篇 |
2022年 | 96篇 |
2021年 | 234篇 |
2020年 | 163篇 |
2019年 | 244篇 |
2018年 | 299篇 |
2017年 | 212篇 |
2016年 | 253篇 |
2015年 | 261篇 |
2014年 | 345篇 |
2013年 | 520篇 |
2012年 | 726篇 |
2011年 | 743篇 |
2010年 | 416篇 |
2009年 | 365篇 |
2008年 | 722篇 |
2007年 | 665篇 |
2006年 | 630篇 |
2005年 | 661篇 |
2004年 | 582篇 |
2003年 | 516篇 |
2002年 | 487篇 |
2001年 | 130篇 |
2000年 | 115篇 |
1999年 | 125篇 |
1998年 | 119篇 |
1997年 | 102篇 |
1996年 | 97篇 |
1995年 | 95篇 |
1994年 | 74篇 |
1993年 | 74篇 |
1992年 | 75篇 |
1991年 | 85篇 |
1990年 | 81篇 |
1989年 | 87篇 |
1988年 | 67篇 |
1987年 | 57篇 |
1986年 | 80篇 |
1985年 | 76篇 |
1984年 | 54篇 |
1983年 | 43篇 |
1982年 | 43篇 |
1981年 | 52篇 |
1980年 | 40篇 |
1979年 | 33篇 |
1978年 | 28篇 |
1977年 | 28篇 |
1976年 | 35篇 |
1975年 | 23篇 |
1966年 | 22篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
91.
E. G. Jones H. D. Schwark P. A. Callahan 《Experimental brain research. Experimentelle Hirnforschung. Expérimentation cérébrale》1986,63(2):310-320
Summary Single and multiunit mapping was used to determine the extent of the representation of ipsilateral structures in the ventral posterior medial (VPM) nucleus of the thalamus in cynomolgus monkeys. The extent of the VPM occupied by terminations of afferent fibers arising in the ipsilateral principal trigeminal nucleus was also determined by anterograde transport of horseradish peroxidase. Both methods indicate that most of the medial half of VPM is occupied by the ipsilateral representation. This is much larger than previously suspected. Units in the medial half of VPM have small, well localized receptive fields on the ipsilateral side of the lower lip, tongue and palate, in the ipsilateral cheek pouch and on the ipsilateral teeth. The representation is largest for the ipsilateral side of the tongue and the cheek pouch. Most units in the lateral half of VPM have small, contralateral receptive fields. Few units in VPM have bilateral receptive fields. VPM is clearly distinguishable by cytochrome oxidase (CO) staining. Anteroposteriorly elongated, CO-positive aggreations correspond to elongated aggregations of units with the same or closely similar receptive fields, especially in the medial, ipsilateral representation.Abbreviations CL
Central lateral nucleus
- CM
Centre médian nucleus
- DCN
Dorsal cochlear nucleus
- DIT
Dorsal ipsilateral trigeminal tract
- IO
Inferior olivary nuclei
- ML
Medial lemniscus
- MV
Motor trigeminal nucleus
- PRV
Principal sensory trigeminal nucleus
- SO
Superior olivary nuclei
- SPV
Spinal trigeminal nucleus
- Ves
Vestibular nuclei
- VMb
Basal ventral medial nucleus
- VPI
Ventral posterior inferior nucleus
- VPL
Ventral posterior lateral nucleus
- VPM
Ventral posterior medial nucleus
- IV
Trochlear nucleus
- VI
Abducens nucleus 相似文献
92.
Genetic polymorphism of cytomegalovirus strains responsible of congenital infections 总被引:1,自引:0,他引:1
Picone O Costa JM Ville Y Chaix ML Rouzioux C Leruez-Ville M 《Pathologie-biologie》2004,52(9):534-539
OBJECTIVES: Congenital Cytomegalovirus (CMV) infection is the main cause of neurological handicap in young children. The objective for studying genetic polymorphism of strains responsible for congenital infection is to identify CMV strains or groups of strains which would be more frequent in this context and/or which would be responsible for more severe congenital infection. METHODS: In this paper, we report and analyze the literature concerning the genetic polymorphism of CMV strains responsible of congenital infection, in the genes coding for the envelop protein B and the non structural UL144 protein and in the CMV short tandem repeats. RESULTS AND CONCLUSION: All UL144 and gB genotypes can be vertically transmitted from mothers to fetuses, none of these studies has shown any link between the genotypes and the severity of congenital disease. Moreover, no link between short tandem repeats polymorphism and severity of congenital disease has been demonstrated. However, short tandem repeats analysis may be a powerful tool to study the epidemiology of CMV congenital infections. 相似文献
93.
Molecular Approaches to Diagnosis of Pulmonary Diseases Due to Mycoplasma pneumoniae 总被引:8,自引:0,他引:8
下载免费PDF全文
![点击此处可从《Journal of clinical microbiology》网站下载免费的PDF全文](/ch/ext_images/free.gif)
Marianne Abele-Horn Ulrich Busch Hans Nitschko Enno Jacobs Ralph Bax Friederike Pfaff Beatrix Schaffer Jürgen Heesemann 《Journal of clinical microbiology》1998,36(2):548-551
In this prospective study, the use of a culture-enhanced PCR assay for the detection of Mycoplasma pneumoniae, followed by hybridization with a specific probe (MP-HPCR) or without hybridization (MP-PCR), and the use of a nested PCR (MP-NPCR) were evaluated. Clinical samples (190 specimens) from 190 patients with respiratory complaints were incubated in culture broth overnight and then subjected to PCR. The results of the PCR were compared to those obtained by culture, the direct antigen test, and serologic testing by microparticle agglutination and by immunoblotting in unclear cases. The sensitivities were 19 CFU for MP-PCR, 1.9 CFU for MP-HPCR, and 0.019 CFU for MP-NPCR. PCR amplification of the β-globin gene was possible in 98% of cases: after dilution of the β-globin-negative samples, all samples were reactive. Correlation between negative MP-NPCR results and negative serology results was found in 89% of cases; a positive correlation was found with 10% of the patients. Samples from three immunocompromised patients were MP-NPCR positive but serologically negative. High respiratory colonization by M. pneumoniae (>105 CFU/ml) in patients with acute respiratory disease could be detected by culture, MP-PCR, and MP-NPCR. These results indicate that MP-PCR and MP-NPCR are reliable methods for the detection of M. pneumoniae in respiratory tract samples of patients with respiratory complaints. 相似文献
94.
Mai-Lei Woo Kinshella Shazmeen Omar Kerri Scherbinsky Marianne Vidler Laura A. Magee Peter von Dadelszen Sophie E. Moore Rajavel Elango The PRECISE Conceptual Framework Working Group 《Nutrients》2021,13(2)
The placenta is a vital, multi-functional organ that acts as an interface between maternal and fetal circulation during pregnancy. Nutritional deficiencies during pregnancy alter placental development and function, leading to adverse pregnancy outcomes, such as pre-eclampsia, infants with small for gestational age and low birthweight, preterm birth, stillbirths and maternal mortality. Maternal nutritional supplementation may help to mitigate the risks, but the evidence base is difficult to navigate. The primary purpose of this umbrella review is to map the evidence on the effects of maternal nutritional supplements and dietary interventions on pregnancy outcomes related to placental disorders and maternal mortality. A systematic search was performed on seven electronic databases, the PROSPERO register and references lists of identified papers. The results were screened in a three-stage process based on title, abstract and full-text by two independent reviewers. Randomized controlled trial meta-analyses on the efficacy of maternal nutritional supplements or dietary interventions were included. There were 91 meta-analyses included, covering 23 types of supplements and three types of dietary interventions. We found evidence that supports supplementary vitamin D and/or calcium, omega-3, multiple micronutrients, lipid-based nutrients, and balanced protein energy in reducing the risks of adverse maternal and fetal health outcomes. However, these findings are limited by poor quality of evidence. Nutrient combinations show promise and support a paradigm shift to maternal dietary balance, rather than single micronutrient deficiencies, to improve maternal and fetal health. The review is registered at PROSPERO (CRD42020160887). 相似文献
95.
Sina Schwarzkopf Adalbert Krawczyk Dietmar Knop Hannes Klump Andreas Heinold Falko M. Heinemann Laura Thümmler Christian Temme Marianne Breyer Oliver Witzke Ulf Dittmer Veronika Lenz Peter A. Horn Monika Lindemann 《Emerging infectious diseases》2021,27(1):122
We investigated immune responses against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) among a group of convalescent, potential blood donors in Germany who had PCR-confirmed SARS-CoV-2 infection. Sixty days after onset of symptoms, 13/78 (17%) study participants had borderline or negative results to an ELISA detecting IgG against the S1 protein of SARS-CoV-2. We analyzed participants with PCR-confirmed infection who had strong antibody responses (ratio >3) as positive controls and participants without symptoms of SARS-CoV-2 infection and without household contact with infected patients as negative controls. Using interferon-γ ELISpot, we observed that 78% of PCR-positive volunteers with undetectable antibodies showed T cell immunity against SARS-CoV-2. We observed a similar frequency (80%) of T-cell immunity in convalescent donors with strong antibody responses but did not detect immunity in negative controls. We concluded that, in convalescent patients with undetectable SARS-CoV-2 IgG, immunity may be mediated through T cells. 相似文献
96.
Wenzel Mike Yu Hang Uhlig Annemarie Würnschimmel Christoph Wallbach Manuel Becker Andreas Fisch Margit Chun Felix K. H. Meyer Christian P. Leitsmann Marianne 《International urology and nephrology》2021,53(10):2041-2049
International Urology and Nephrology - To test the value of preoperative and postoperative cystatin C (CysC) as a predictor on kidney function after partial (PN) or radical nephrectomy (RN) in... 相似文献
97.
Edoardo Maria Muttillo Tristan Dégot Matthieu Canuet Marianne Riou Benjamin Renaud-Picard Sandrine Hirschi Blandine Guffroy Romain Kessler Anne Olland Pierre-Emmanuel Falcoz Patrick Pessaux Emanuele Felli 《Transplantation proceedings》2021,53(2):692-695
BackgroundDiffuse large B-cell lymphoma (DLBCL) is the most common subtype of non–Hodgkin lymphoma in the posttransplant setting. Treatment is based on chemotherapy; surgery is still debated and should be performed in very select cases.MethodsWe observed 2 patients out of 300 who underwent lung transplantation in the Nouvel Hopital Civil between 2013 and 2019 with primary hepatic lymphoma. Chemotherapy with a rituximab-cyclophosphamide, hydroxydaunorubicin, vincristine, prednisone protocol was performed in all patients. Mycophenolate mofetil was interrupted before treatment, and everolimus was introduced after chemotherapy by associating tacrolimus withdrawal.ResultsOne patient showed complete remission; after 7 years, no recurrence has been noticed. The second is still undergoing chemotherapy with no signs of disease progression.ConclusionsDLBCL risk is higher in solid organ transplant recipients than in the general population. Primary hepatic lymphoma diagnosis is often difficult and based on histologic findings after initial clinical and radiological suspicion of primary or secondary liver neoplasia. Diagnosis is challenging because no clinical, radiological, or biological features exist. Biopsy is always indicated for histologic confirmation. Chemotherapy is the mainstay of therapy, but surgery may be indicated in very select patients. 相似文献
98.
99.
100.
Nathalie Chavarot Gillian Divard Anne Scemla Lucile Amrouche Olivier Aubert Marianne Leruez-Ville Marc O. Timsit Claire Tinel Julien Zuber Christophe Legendre Dany Anglicheau Rebecca Sberro-Soussan 《American journal of transplantation》2021,21(7):2448-2458
Belatacept may increase cytomegalovirus (CMV) disease risk after conversion from CNI-based therapy. We analyzed CMV disease characteristics after belatacept conversion. Propensity score matching was used to compare CMV disease incidence in belatacept- and CNI-treated kidney transplant recipients (KTRs). CMV disease characteristics and risk factors under belatacept were analyzed. In total, 223 KTRs (median age [IQR] 59.2 years [45.4–68.5]) were converted to belatacept (median of 11.5 months [2.5–37.0] post-transplantation); 40/223 (17.9%) developed CMV disease. Independent risk factors included increased age (p = .0164), D+/R− CMV serostatus (p = .0220), and low eGFR at conversion (p = .0355). Among 181 belatacept-treated patients matched to 181 controls, 32/181 (17.7%) experienced CMV disease (vs. 5/181 controls [2.8%]). CMV disease cumulative incidences were 6.33 and 0.91/100 person-years (p-y) in belatacept and control groups, respectively. CMV disease risk was particularly high in elderly patients (converted >70 years) and those with eGFR <30 ml/min; cumulative incidences were 18.4 and 5.2/100 p-y, respectively. CMV diseases under belatacept were atypical, with late-onset disease (24/40 patients [60%]), high CMV seropositivity (27/40, 67%), increased severe and tissue-invasive disease rates (gastrointestinal involvement in 32/40 [80%]) and life-threatening diseases (4/40 [10%]). These findings should stimulate further research to secure the use of belatacept as a valuable rescue therapy in KTRs. 相似文献